Paper2376397
Prognostic factors in anal squamous carcinoma: a multivariate analysis of clinical, pathological and flow cytometric parameters in 235 cases.
Shepherd NA and 4 others. Histopathology, 1990. Cited by 38 papers, by iCite.
Cite this record
ConductScience Library. Prognostic factors in anal squamous carcinoma: a multivariate analysis of clinical, pathological and flow cytometric parameters in 235 cases. Papers, record 2376397. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2376397
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Prognostic factors in anal squamous carcinoma: a multivariate analysis of clinical, pathological and flow cytometric parameters in 235 cases.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anus Neoplasms | Major topic |
| Carcinoma, Squamous Cell | Major topic |
| Adult | |
| Aged | |
| Aged, 80 and over | |
| Biopsy | |
| Female | |
| Flow Cytometry | |
| Humans | |
| Male | |
| Middle Aged | |
| Multivariate Analysis | |
| Prognosis | |
| Retrospective Studies | |
| Survival Rate |
Source PubMed
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 38 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42629537 | Stage-dependent differences of long-term outcomes between chemoradiotherapy and surgery for squamous cell carcinoma of the anal canal: a multicenter retrospective cohort study. | Int J Clin Oncol | 2026 | https://conductscience.org/library/papers/42629537 | PubMed |
| 41301019 | Integrating PET and MRI Radiomics for Staging and Prognostic Stratification in Anal Canal Cancer. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/41301019 | PubMed |
| 30345043 | Mucoepidermoid carcinoma of the anal canal: A case report and review of the literature. | Mol Clin Oncol | 2018 | https://conductscience.org/library/papers/30345043 | PubMed |
| 28261646 | Background and Current Treatment of Squamous Cell Carcinoma of the Anus. | Oncol Ther | 2016 | https://conductscience.org/library/papers/28261646 | PubMed |
| 23197880 | New approach to anal cancer: individualized therapy based on sentinel lymph node biopsy. | World J Gastroenterol | 2012 | https://conductscience.org/library/papers/23197880 | PubMed |
| 22619735 | Metastatic squamous cell carcinoma of the anus: time for a shift in the treatment paradigm? | ISRN Oncol | 2012 | https://conductscience.org/library/papers/22619735 | PubMed |
| 19259318 | Prognostic factors for squamous cell cancer of the anal canal. | Gastrointest Cancer Res | 2008 | https://conductscience.org/library/papers/19259318 | PubMed |
| 16916475 | Local tumor control and toxicity in HIV-associated anal carcinoma treated with radiotherapy in the era of antiretroviral therapy. | Radiat Oncol | 2006 | https://conductscience.org/library/papers/16916475 | PubMed |
| 8024357 | Recurrent squamous cell carcinoma of the anal canal. Predictors of initial treatment failure and results of salvage therapy. | Ann Surg | 1994 | https://conductscience.org/library/papers/8024357 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2376397
GET https://conductscience.org/api/papers/v1/2376397/authors